Clinical trial
The Effects of Metabolic Parameters of Aripiprazole in Patients With Schizophrenia
NCT00569764 is registered in ClinicalTrials.gov with Seoul National Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Metabolic Parameters of Aripiprazole in Patients With Schizophrenia
- Lead sponsor
- Seoul National Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2007
- Completion date
- October 31, 2009
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.